Feng XQ - Search Results

1

[Association of small dense low-density lipoprotein cholesterol with H-type hypertension and MTHFR gene polymorphism].

Li Q, Sun XL, Song B, Lyu CX, Feng XQ. Li Q, et al. Among authors: feng xq. Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Dec 6;56(12):1844-1849. doi: 10.3760/cma.j.cn112150-20220719-00736. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 36536576 Chinese.

2

The heterogeneity of tissue destruction between iron rim lesions and non-iron rim lesions in multiple sclerosis: A diffusion MRI study.

Hu H, Ye L, Ding S, Zhu Q, Yan Z, Chen X, Chen G, Feng X, Li Q, Li Y. Hu H, et al. Mult Scler Relat Disord. 2022 Oct;66:104070. doi: 10.1016/j.msard.2022.104070. Epub 2022 Jul 26. Mult Scler Relat Disord. 2022. PMID: 35914471

3

The analysis of factors associated with progression of isolated terminal ileal lesions.

Fangbin Z, Weiwei H, Wugan Z, Cong Z, Yanjun C, Feng X. Fangbin Z, et al. PLoS One. 2014 Mar 13;9(3):e90797. doi: 10.1371/journal.pone.0090797. eCollection 2014. PLoS One. 2014. PMID: 24625578 Free PMC article.

4

Analysis of Related Influencing Factors of Portal Vein Thrombosis After Hepatectomy.

Qi S, Tao J, Wu X, Feng X, Feng G, Shi Z. Qi S, et al. J Laparoendosc Adv Surg Tech A. 2024 Mar;34(3):246-250. doi: 10.1089/lap.2023.0455. Epub 2024 Jan 22. J Laparoendosc Adv Surg Tech A. 2024. PMID: 38252557

5

Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.

Fangbin Z, Xiang G, Liang D, Hui L, Xueding W, Baili C, Huichang B, Yinglian X, Peng C, Lizi Z, Yanjun C, Feng X, Minhu C, Min H, Pinjin H. Fangbin Z, et al. Medicine (Baltimore). 2016 Apr;95(15):e3326. doi: 10.1097/MD.0000000000003326. Medicine (Baltimore). 2016. PMID: 27082580 Free PMC article.

6

Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?

Fangbin Z, Xiang G, Minhu C, Liang D, Feng X, Min H, Pinjin H. Fangbin Z, et al. Ther Drug Monit. 2012 Dec;34(6):695-701. doi: 10.1097/FTD.0b013e3182731925. Ther Drug Monit. 2012. PMID: 23149442

7

Relationships Among Serological Indicators and In Vitro High-Throughput Drug Sensitivity Screening Results in Patients with Hepatocellular Carcinoma.

Feng X, Feng GY, Tao J, Ao YP, Wu XH, Qi SG, Shi ZR, Gao LY. Feng X, et al. Comb Chem High Throughput Screen. 2024 Jun 26. doi: 10.2174/0113862073305230240611091708. Online ahead of print. Comb Chem High Throughput Screen. 2024. PMID: 38934277

8

A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection.

Li X, Chen K, Feng X, Wu X, Qi S, Wang Q, Shi Z. Li X, et al. J Hepatocell Carcinoma. 2024 Oct 29;11:2101-2113. doi: 10.2147/JHC.S483397. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39493264 Free PMC article.

9

Development and Validation of a Risk Prediction Algorithm for Evaluating the Efficacy of Postoperative Adjuvant TACE Therapy for Hepatocellular Carcinoma.

Tao J, Shi X, Feng X, Wu X, Qi S, Feng G, Yang X, Zhao Y, Zuo H, Shi Z. Tao J, et al. Comb Chem High Throughput Screen. 2024;27(8):1111-1118. doi: 10.2174/1386207326666230824090204. Comb Chem High Throughput Screen. 2024. PMID: 37622693

10

An orally antitumor chalcone hybrid inhibited HepG2 cells growth and migration as the tubulin binding agent.

Yan W, Xiangyu C, Ya L, Yu W, Feng X. Yan W, et al. Invest New Drugs. 2019 Aug;37(4):784-790. doi: 10.1007/s10637-019-00737-z. Epub 2019 Feb 11. Invest New Drugs. 2019. PMID: 30740631

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters